Potential benefit of angiotensin II in COVID-19 patients: Beyond reasonable doubt?

António Tralhão*, Luís Ferreira Moita, Pedro Póvoa

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
Article number324
JournalCritical Care
Volume24
ISSN1364-8535
DOIs
Publication statusPublished - 9. Jun 2020

Keywords

  • Angiotensin II
  • Betacoronavirus
  • Coronavirus Infections
  • Humans
  • Pandemics
  • Pneumonia, Viral

Cite this